Renata B. De Oliveira

6627, Antônio Carlos Avenue
Belo Horizonte, MG 31270901, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Dual Antitumor and Antifungal Potential of Terpene and Propenylbenzene Amines.

Dual Antitumor and Antifungal Potential of Terpene and Propenylbenzene Amines.

Journal: Current medicinal chemistry

Published: October 09, 2025

Novel 2-Thiazolylhydrazone with Druggable Properties for Antifungal Application.

Novel 2-Thiazolylhydrazone with Druggable Properties for Antifungal Application.

Journal: Journal of fungi (Basel, Switzerland)

Published: January 01, 2025

Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors.

Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors.

Journal: Pathogens (Basel, Switzerland)

Published: August 20, 2024

Investigation of the activity of 4-aminoquinolines as cysteine protease inhibitors with application in the treatment of Chagas disease.

Investigation of the activity of 4-aminoquinolines as cysteine protease inhibitors with application in the treatment of Chagas disease.

Journal: Memorias do Instituto Oswaldo Cruz

Published: July 17, 2024

New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease.

New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease.

Journal: Expert opinion on drug discovery

Published: May 08, 2024

Machine Learning-Based Virtual Screening of Antibacterial Agents against Methicillin-Susceptible and Resistant Staphylococcus aureus.

Machine Learning-Based Virtual Screening of Antibacterial Agents against Methicillin-Susceptible and Resistant Staphylococcus aureus.

Journal: Journal of chemical information and modeling

Published: March 04, 2024

Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets.

Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets.

Journal: Expert opinion on therapeutic targets

Published: September 29, 2023

Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitors.

Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitors.

Journal: Future medicinal chemistry

Published: July 12, 2023

Experimental and Computational Study of Aryl-thiosemicarbazones Inhibiting Cruzain Reveals Reversible Inhibition and a Stepwise Mechanism.

Experimental and Computational Study of Aryl-thiosemicarbazones Inhibiting Cruzain Reveals Reversible Inhibition and a Stepwise Mechanism.

Journal: Journal of chemical information and modeling

Published: February 21, 2023

Screening the Pathogen Box to Discover and Characterize New Cruzain and TbrCatL Inhibitors.

Screening the Pathogen Box to Discover and Characterize New Cruzain and TbrCatL Inhibitors.

Journal: Pathogens (Basel, Switzerland)

Published: December 22, 2022

Reply to "Antiseptic Mouthwashes and Mortality: Look Beyond Chlorhexidine".

Reply to "Antiseptic Mouthwashes and Mortality: Look Beyond Chlorhexidine".

Journal: Medicina intensiva

Published: August 30, 2022

From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds.

From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds.

Journal: European journal of medicinal chemistry

Published: July 30, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026